These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 38582700

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.
    Hashimoto T, Ohzono A, Teye K, Numata S, Hiroyasu S, Tsuruta D, Hachiya T, Kuroda K, Hashiguchi M, Kawakami T, Ishii N.
    Br J Dermatol; 2017 Jul; 177(1):141-151. PubMed ID: 27716903
    [Abstract] [Full Text] [Related]

  • 4. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N, Lüttmann N, Huebner F, Recke A, Karl I, Schulze FS, Zillikens D, Schmidt E.
    JAMA Dermatol; 2017 Jan 01; 153(1):30-38. PubMed ID: 27829102
    [Abstract] [Full Text] [Related]

  • 5. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S, Yuan H, Lin C, Pan M, Hundt JE, Schmidt E, Komorowski L, Stanley JR, Hammers CM.
    Br J Dermatol; 2019 May 01; 180(5):1099-1106. PubMed ID: 30315657
    [Abstract] [Full Text] [Related]

  • 6. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M, Ghiasi M, Lajevardi V, Nasiri N, Balighi K, Teimourpour A, Khosravi H, Saeidi V, Mahmoudi H, Chams-Davatchi C.
    Arch Dermatol Res; 2018 Apr 01; 310(3):255-259. PubMed ID: 29423547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
    Bing L, Xiping Z, Li L, Jun P, Yi-Xia W, Min Y, Qing L, Qiu-Ning S, Hong-Zhong J, Ya-Gang Z.
    Arch Dermatol Res; 2015 Nov 01; 307(9):849-54. PubMed ID: 26404084
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM, Goletz S, van Beek N, Zillikens D, Benoit S, Harman K, Walton S, English J, Sticherling M, Chapman A, Levell NJ, Groves R, Williams HC, König IR, Schmidt E, members of the BLISTER Study Group.
    Br J Dermatol; 2018 Oct 01; 179(4):918-924. PubMed ID: 29607480
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
    Zheng M, Ujiie H, Iwata H, Muramatsu K, Yoshimoto N, Ito T, Ujiie I, Shimizu S, Sato-Matsumura KC, Shimizu H.
    J Eur Acad Dermatol Venereol; 2019 Mar 01; 33(3):595-600. PubMed ID: 30394605
    [Abstract] [Full Text] [Related]

  • 13. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
    Ghohestani RF, Cozzani E, Delaporte E, Nicolas JF, Parodi A, Claudy A.
    J Clin Immunol; 1998 May 01; 18(3):202-9. PubMed ID: 9624579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of BP230 autoantibodies in bullous pemphigoid.
    Shih YC, Wang B, Yuan H, Zheng J, Pan M.
    J Dermatol; 2020 Apr 01; 47(4):317-326. PubMed ID: 32048350
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK, Sitaru C, Recke A, Oostingh GJ, Zillikens D, Gibbs BF.
    Br J Dermatol; 2009 Feb 01; 160(2):429-32. PubMed ID: 18808416
    [Abstract] [Full Text] [Related]

  • 18. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
    Iwata Y, Komura K, Kodera M, Usuda T, Yokoyama Y, Hara T, Muroi E, Ogawa F, Takenaka M, Sato S.
    Arch Dermatol; 2008 Jan 01; 144(1):41-8. PubMed ID: 18209167
    [Abstract] [Full Text] [Related]

  • 19. Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: Restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins.
    Hayakawa T, Teye K, Hachiya T, Uehara R, Hashiguchi M, Kawakami T, Li X, Tsuchisaka A, Ohara K, Sogame R, Koga H, Hamada T, Ohata C, Furumura M, Ishii N, Fukano H, Shimozato K, Hashimoto T.
    Eur J Dermatol; 2016 Apr 01; 26(2):155-63. PubMed ID: 27087683
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.